Pharmaceutical Hot Melt Extrusion Equipment Market By Usage Area (Research and Academia, Contract Manufacturing Organization, Pharmaceutical Companies), By Product (RAM Extruders, Radial Screen Equipment, Roll and Screw Extruders) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Hot melt extrusion (HME) is the process of melting polymers and continuously forcing them through an orifice using heat and a press. The HME process has been developed for producing polymer products with uniform shape and density and has been used in industrial applications since the 1930s. Recently, HME technology has been brought into use in pharmaceutical applications, where it is predominantly used for manufacturing APIs with polymers to augment bioavailability or prepare precursors for thermoplastic drug-eluting devices. This report discusses the principles of HME equipment in pharmaceutical manufacturing, along with its future prospects and applications.

The purpose of this research study titled "Pharmaceutical Hot Melt Extrusion Equipment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global pharmaceutical hot melt extrusion equipment market. This report presents and analyses the major trends prevalent in the global pharmaceutical hot melt extrusion equipment market and the market size and forecast.

This report categorizes the global pharmaceutical hot melt extrusion equipment market in terms of product type, usage area, and geographical distribution. Based on product type, the global pharmaceutical hot melt extrusion equipment market is categorized into ram extruders, radial screen equipment, and roll and screw extruders. The roll and screw extruders segment is further categorized into single-screw extruders (SSEs), twin-screw extruders (TSEs), and multi-screw extruders (MSEs). Research and academia, contract manufacturing organizations, and pharmaceutical companies are the major usage areas considered for the purpose of this study. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global pharmaceutical hot melt extrusion equipment market is best understood by segmenting it into five major regions and five major region-level markets, as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectionally presented in terms of product, usage area, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global pharmaceutical hot melt extrusion equipment market. A qualitative analysis of various application areas of the pharmaceutical hot melt extrusion process is also presented in a separate chapter of the report. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the pharmaceutical hot melt extrusion equipment market. The key players profiled in this report are Baker Perkins Ltd., Coperion GmbH, Gabler GmbH & Co. KG, Milacron Holdings Corp., Leistritz Advanced Technologies Corp., Thermo Fisher Scientific, Inc., and Xtrutech Ltd.

The global pharmaceutical hot melt extrusion equipment market is being studied for its application in the following areas for the purposes of this study:

  • Research and academia
  • Contract Manufacturing Organization
  • Pharmaceutical Companies

Among the considered usage areas, pharmaceutical companies, research, and academia together are the largest segments in the pharmaceutical hot melt extrusion equipment market. The widespread adoption of hot melt extrusion systems in pharmaceutical production and the perpetual urge to include more drugs under its coverage are the key factors contributing to the dominance of pharmaceutical companies. Hot melt extrusion is used to manufacture several drug delivery systems, such as granules, pellets, oral fast-dissolving systems, tablets (immediate and delayed release), translingual, transdermal, and transmucosal delivery systems, and implants. The introduction of additional polymers to be combined in HME with APIs will open further avenues in the market.

The global pharmaceutical hot melt extrusion equipment market is studied for the following product types:

  • RAM Extruders
  • Radial Screen Equipment
  • Roll and Screw Extruders
  • Single-screw extruders (SSEs)
  • Twin-screw extruders (TSEs)
  • Multi-screw extruders (MSEs)

TSE is the most widely used melt extrusion process used for solid dosage manufacturing. The TSE involves agitator assemblies, which permit different configurations from material feeding to rotating screws and conveying material to a metered pumping zone. There are several types of TSEs available to fit distinct operating mechanisms and processing applications. The TSE screws can either rotate in the same direction or inversely. These TSE types are further categorized as fully intermeshing or non-intermeshing. Between these, the former is more commonly used because of its self-cleaning feature and prevention of localized overheating of raw material. The non-intermeshing variants are less popular due to a weaker screw system and less cleaning capability.

Geographically, the global pharmaceutical hot melt extrusion equipment market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

North America and Europe dominate the global pharmaceutical hot melt extrusion equipment market. The presence of several prominent research centers and pioneer drug manufacturers mainly contributes to the dominance of the North American market. Perpetual adoption of novel technical solutions in healthcare infrastructure and pharmaceutical manufacturing and extensive research initiatives contribute to the dominance of Europe on the global front. Additionally, the rapid proliferation of CMO activities in the Asia Pacific, with a growing base of skilled researchers, will make this region the fastest-progressing regional market during the forecast period of 2017–2025.

The detailed regional classification of the global pharmaceutical hot melt extrusion equipment market is as follows:

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, and the Rest of Europe)
  • Asia Pacific (China, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Questions:

The market for Pharmaceutical Hot Melt Extrusion Equipment is expected to reach US$ 39 Mn in 2025.

The Pharmaceutical Hot Melt Extrusion Equipment market is expected to see significant CAGR growth over the coming years,at 4.5%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Baker Perkins Ltd.,Coperion GmbH,Gabler GmbH & Co. KG,Milacron Holdings Corp.,Leistritz Advanced Technologies Corp. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Oct 2017
Category:  Pharmaceuticals
Report ID:   58743
Report Format:   PDF
Pages:   120
Rating:    4.8 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support